Zobrazeno 1 - 4
of 4
pro vyhledávání: '"JeanAnne M. Ware"'
Urine eosinophil‐derived neurotoxin: A potential marker of activity in select eosinophilic disorders
Autor:
Michelle A. Makiya, Paneez Khoury, Fei Li Kuang, Alexis Dominique Mata, Sana Mahmood, Abbie Bowman, David Espinoza, Nicholas Kovacs, Thomas Brown, Nicole Holland, Lauren Wetzler, JeanAnne M. Ware, Anne‐Marie Dyer, Praveen Akuthota, Bruce S. Bochner, Vernon M. Chinchilli, Gerald J. Gleich, Carol Langford, Peter A. Merkel, Ulrich Specks, Peter F. Weller, Michael E. Wechsler, Calman Prussin, Michael P. Fay, Amy D. Klion
Publikováno v:
Allergy. 78:258-269
Biomarkers of eosinophilic disease activity, especially in the context of novel therapies that reduce blood eosinophil counts, are an unmet need. Absolute eosinophil count (AEC) does not accurately reflect tissue eosinophilia or eosinophil activation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::242fcff47ab23119531e62cff84dccff
https://doi.org/10.1111/all.15481
https://doi.org/10.1111/all.15481
Publikováno v:
The journal of allergy and clinical immunology. In practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b5c5c1dd27e990d7a44c4a6e83f495
https://pubmed.ncbi.nlm.nih.gov/36621605
https://pubmed.ncbi.nlm.nih.gov/36621605
Autor:
Fei Li, Kuang, Michelly Sampaio, De Melo, Michelle, Makiya, Sheila, Kumar, Thomas, Brown, Lauren, Wetzler, JeanAnne M, Ware, Paneez, Khoury, Margaret H, Collins, Martha, Quezado, Stefania, Pittaluga, Amy D, Klion
Publikováno v:
J Allergy Clin Immunol Pract
BACKGROUND: Previous studies of targeted eosinophil biologics in eosinophilic esophagitis have yielded mixed results. Possible explanations include incomplete eosinophil depletion with anticytokine (anti–IL-5) treatments and/or irreversible fibroti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6955b8db4ec9e20500eaa7c2808d5820
https://europepmc.org/articles/PMC9210216/
https://europepmc.org/articles/PMC9210216/
Autor:
Michael M. Chen, Florence Roufosse, Sa A. Wang, Srdan Verstovsek, Sandy R. Durrani, Marc E. Rothenberg, Thanai Pongdee, Joseph Butterfield, Timothy Lax, Michael E. Wechsler, Miguel L. Stein, Princess U. Ogbogu, Basil M. Kahwash, Sameer K. Mathur, Dagmar Simon, Praveen Akuthota, Nicole Holland, Lauren Wetzler, JeanAnne M. Ware, Canting Guo, Michael P. Fay, Paneez Khoury, Amy D. Klion, Bruce S. Bochner
Publikováno v:
J Allergy Clin Immunol Pract
Chen, Michael M; Roufosse, Florence; Wang, Sa A; Verstovsek, Srdan; Durrani, Sandy R; Rothenberg, Marc E; Pongdee, Thanai; Butterfield, Joseph; Lax, Timothy; Wechsler, Michael E; Stein, Miguel L; Ogbogu, Princess U; Kahwash, Basil; Mathur, Sameer K; Simon, Dagmar; Akuthota, Praveen; Holland, Nicole; Wetzler, Lauren; Ware, JeanAnne M; Guo, Canting; ... (2022). An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes. The journal of allergy and clinical immunology. In practice, 10(5), 1217-1228.e3. Elsevier 10.1016/j.jaip.2022.02.006
Chen, Michael M; Roufosse, Florence; Wang, Sa A; Verstovsek, Srdan; Durrani, Sandy R; Rothenberg, Marc E; Pongdee, Thanai; Butterfield, Joseph; Lax, Timothy; Wechsler, Michael E; Stein, Miguel L; Ogbogu, Princess U; Kahwash, Basil; Mathur, Sameer K; Simon, Dagmar; Akuthota, Praveen; Holland, Nicole; Wetzler, Lauren; Ware, JeanAnne M; Guo, Canting; ... (2022). An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes. The journal of allergy and clinical immunology. In practice, 10(5), 1217-1228.e3. Elsevier 10.1016/j.jaip.2022.02.006
BACKGROUND Treatment of hypereosinophilic syndrome (HES) often requires the use of immunomodulators with substantial side effect profiles. The emergence of biologics offers an alternative treatment modality. OBJECTIVE To examine real world practice d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0bd3a33b737003ac1f8b193ff604486